As the use of GLP-1s, like Ozempic, has skyrocketed in the U.S., two researchers at UMass Chan Medical School in Worcester have received a $2 million award from the Centers for Disease Control and Prevention to study lifestyle change of those taking the popular drug.
CDC awards UMass Chan $2M to study GLP-1 lifestyle changes
